Characterizing real-world functional outcomes in patients with geographic atrophy: An IRIS Registry Analysis

Research Lead:

Ted Leng, MD

Real-World Clinical and Anatomical Outcomes in Patients with Diabetic Macular Edema Treated with Faricimab: The FARETINA-DME Study

May 9, 2024
Read More

IRIS® Registry Analysis of Anti-VEGF Treatment in Patients With Coexisting Neovascular Age-Related Macular Degeneration and Geographic Atrophy

May 9, 2024
Read More

A Natural Language Processing Approach to Identify Patients with Uveitic Macular Edema in the IRIS®️ Registry

May 6, 2024
Read More

Automated Segmentation of Geographic Atrophy Using Machine Learning on Real-World Fundus Autofluorescence Ophthalmic Images in the IRIS®️ Registry

May 6, 2024
Read More

Real-World Clinical and Anatomical Outcomes in Patients With Neovascular Age-Related Macular Degeneration Treated With Faricimab: The FARETINA-AMD Study

May 6, 2024
Read More

Leveraging real-world data from the American Academy of Ophthalmology’s IRIS®️ Registry to evaluate the use and impact of approved medical devices and software algorithms in support of FDA strategic priorities

April 10, 2024
Read More

Ab Interno Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery and Cataract Surgery Alone: IRIS®️ Registry Study

April 7, 2024
Read More

Comparison of Methods of Clinical Trial Emulation Utilizing Data from the Comparison of AMD Treatment Trial (CATT) and the IRISⓇ Registry

April 3, 2024
Read More

Multi-registry analysis of patients with multiple sclerosis and neuromyelitis optica to improve capture of demographic data and compare visual outcomes

February 11, 2024
Read More

Vitreoretinal Specialist Use of Ancillary Testing: An IRIS®️ Registry Analysis

October 20, 2023
Read More
Qdata

Talk to a Qdata Expert

Take a minute to submit your contact information and one of our team members will reach out to you.